| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.091 | 0.1 |